A detailed history of Phar Vision Advisers, LLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 41,386 shares of ANIK stock, worth $411,376. This represents 0.22% of its overall portfolio holdings.

Number of Shares
41,386
Holding current value
$411,376
% of portfolio
0.22%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$8.1 - $11.78 $335,226 - $487,527
41,386 New
41,386 $389 Million

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $145M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Phar Vision Advisers, LLC Portfolio

Follow Phar Vision Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phar Vision Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Phar Vision Advisers, LLC with notifications on news.